Review

TRASTUZUMAB BEYOND PROGRESSION IN PATIENTS WITH HER-2/NEU POSITIVE METASTATIC BREAST CANCER
  • Yeşim Eralp
Eur J Breast Health 2009; 5: 3-8
SYSTEMIC TREATMENT IN DUCTAL CARCINOMA IN SITU
  • Bülent Karagöz
  • Oğuz Bilgi
Eur J Breast Health 2013; 9: 44-47 DOI: 10.5152/tjbh.2013.02

Original Article

An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction
  • İrfan Cicin
  • Mohammed Oukkal
  • Hassen Mahfouf
  • Amel Mezlini
  • Blaha Larbaoui
  • Slim Ben Ahmed
  • Hassan Errihani
  • Khalid Alsaleh
  • Rhizlane Belbaraka
  • Perran Fulden Yumuk
  • Burce Goktas
  • Mustafa Özgüroğlu
Eur J Breast Health 2022; 18: 63-73 DOI: 10.4274/ejbh.galenos.2021.2021-9-9 PMID:35059593

Case Report

RECURRENT SUPRAVENTRICULAR TACHYCARDIA ASSOCIATED WITH LAPATINIB: A CASE REPORT OF A PROBABLE CARDIAC ADVERSE EFFECT
  • Özgür Tanrıverdi
  • Nezih Meydan
  • Sabri Barutca
Eur J Breast Health 2011; 7: 188-190